The history and development of HER2 inhibitors

X Xia, C Gong, Y Zhang, H Xiong - Pharmaceuticals, 2023 - mdpi.com
HER2 is highly expressed in a variety of malignant tumors and affects the prognosis of
patients, making it a highly sensitive target for cancer therapy. Since the approval of the first …

Nano-engineering nanomedicines with customized functions for tumor treatment applications

Y Wang, S Li, X Ren, S Yu, X Meng - Journal of Nanobiotechnology, 2023 - Springer
Nano-engineering with unique “custom function” capability has shown great potential in
solving technical difficulties of nanomaterials in tumor treatment. Through tuning the size …

Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment

M Rahban, S Joushi, H Bashiri, L Saso… - Frontiers in …, 2024 - frontiersin.org
Glioblastoma multiforme (GBM) is a highly aggressive malignant primary tumor in the central
nervous system. Despite extensive efforts in radiotherapy, chemotherapy, and neurosurgery …

Pleiotropic physiological functions of Piezo1 in human body and its effect on malignant behavior of tumors

Y Zhang, W Zou, W Dou, H Luo, X Ouyang - Frontiers in Physiology, 2024 - frontiersin.org
Mechanosensitive ion channel protein 1 (Piezo1) is a large homotrimeric membrane protein.
Piezo1 has various effects and plays an important and irreplaceable role in the maintenance …

Anti‐HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone‐Fused Enediyne

X Feng, Z Wen, X Zhu, X Yan, Y Duan… - Advanced …, 2024 - Wiley Online Library
Although natural products are essential sources of small‐molecule antitumor drugs, some
can exert substantial toxicities, limiting their clinical utility. Anthraquinone‐fused enediyne …

Crosstalk Between Adipocyte and Breast Cancer Cells With ESR Mutations via Adipsin Enhances Tumor Growth

A Belyakov - 2023 - search.proquest.com
Estrogen receptor positive breast cancer is a prevalent disease traditionally treated with
hormone therapy which relies on the expression of the estrogen receptor to starve the tumor …

UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer

W Yuan, J Han, Z Wu, Y Huang, M Deng, C Chen, Y Xu… - 2023 - researchsquare.com
Background Ubiquitination is a targeted protein modification process mediated by
intracellular molecules. UBR1 encodes a protein that binds to unstable N-terminal residues …